Clinical Validation of a Soluble TCR Bispecific Platform: Emerging Lessons from Tebentafusp Development

Abstract not yet added

Date: 16 November 2021, 15:00 (Tuesday, 6th week, Michaelmas 2021)
Venue: Please use this link to join the meeting; https://teams.microsoft.com/l/meetup-join/19%3ameeting_NGQ5YjM4YzktYjBmZS00ODE5LWI1ZjYtYWZmNzBjYTM4MTk2%40thread.v2/0?context=%7b%22Tid%22%3a%22cc95de1b-97f5-4f93-b4ba-fe68b852cf91%22%2c%22Oid%22%3a%2202163093-bdcb-4df2-8059-4f4f65639906%22%7d
Speaker: Dr Mohammed Dar (Immunocore)
Organising department: Medical Sciences Division
Organiser: Dr Georgina Kerr (University of Oxford)
Hosts: Prof. Paul Klenerman (Peter Medawar Building, NDM, Oxford), Prof Tim Elliott (University of Oxford)
Part of: Oxford-Immunocore seminar series
Booking required?: Not required
Audience: Members of the University only
This talk features in the following public collections:
- Talks of Interest to Medical Sciences
Editor: Georgina Kerr